High Impact Research Project Award
2019 (Cycle 30)
| Determining Risk of Transfer of Hookah Tobacco Thirdhand Smoke | 2019 (Cycle 30) | $1,128,750 |
| San Diego State University Research Foundation | Environmental Exposure/Toxicology | |
| What is the local lung dose of smoke from emerging tobacco products? | 2019 (Cycle 30) | $935,724 |
| University of California, Davis | Environmental Exposure/Toxicology | |
| Tobacco and cannabis exposure during pregnancy in six race/ethnic subgroups in California | 2019 (Cycle 30) | $960,000 |
| Sequoia Foundation | Environmental Exposure/Toxicology | |
| The impact of cartoon-based marketing strategies on e-cigarette appeal and use among adolescents | 2019 (Cycle 30) | $1,225,843 |
| University of Southern California | State and Local Tobacco Control Policy Research | |
| Multilevel prevention of commercial tobacco-related harms on rural California Tribal lands | 2019 (Cycle 30) | $1,102,650 |
| PIRE California, Inc. | Tobacco-Use Prevention and Cessation | |
| The impact of price on the demand for marijuana and cigarettes | 2019 (Cycle 30) | $937,500 |
| University of California, San Francisco | State and Local Tobacco Control Policy Research | |
| Youth-initiated tobacco harm reduction? A qualitative study of sexual and gender minorities | 2019 (Cycle 30) | $1,070,979 |
| Scientific Analysis Corporation | Tobacco-Use Prevention and Cessation | |
| The Impact of Recreational Marijuana Legalization on Tobacco and Marijuana Co-Use | 2019 (Cycle 30) | $1,091,974 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Are mothers and their children at risk from in utero exposure to grandmaternal smoking? | 2019 (Cycle 30) | $952,370 |
| Sequoia Foundation | Environmental Exposure/Toxicology | |
2019 (Cycle 29)
| Large scale analyses of generic smoking interaction on cardiometabolic traits | 2019 (Cycle 29) | $874,673 |
| University of California, San Diego | Cardiovascular and Cerebrovascular Disease | |
| Targeting aggressive kidney cancer cells deficient in a metabolic enzyme | 2019 (Cycle 29) | $937,500 |
| University of California, Davis | Cancer | |
| Underlying Mechanisms Regulating the Effects of Inhaled Nicotine upon Abdominal Aortic Aneurysm | 2019 (Cycle 29) | $1,044,000 |
| Palo Alto Veterans Institute For Research | Cardiovascular and Cerebrovascular Disease | |
| Pulmonary Neuroendocrine Cells as a Sensor in Tobacco Induced Lung Diseases | 2019 (Cycle 29) | $937,500 |
| University of California, San Diego | Pulmonary Disease | |
| Fetal nicotine exposure develops heart ischemia-sensitive phenotype | 2019 (Cycle 29) | $1,185,000 |
| Loma Linda University | Cardiovascular and Cerebrovascular Disease | |
| Gestational E-Cigarette Exposure, Transgenerational Asthma, and the Germ Cell Epigenetic Memory | 2019 (Cycle 29) | $1,048,215 |
| LA Biomedical Research Institute at Harbor-UCLA Medical Center | Pulmonary Disease | |
| A Community Based Approach to Tobacco Control | 2019 (Cycle 29) | $974,719 |
| Loyola Marymount University | State and Local Tobacco Control Policy Research | |
| Long-term impact of cannabis exposure on the adolescent brain | 2019 (Cycle 29) | $937,500 |
| University of California, Irvine | Neuroscience of Nicotine Addiction and Treatment | |
| Combined intranasal oxytocin and mindfulness training as a novel treatment for smoking cessation | 2019 (Cycle 29) | $1,231,893 |
| University of Southern California | Tobacco-Use Prevention and Cessation | |
| Disparities in Rates & Impact of Tobacco and Marijuana Use in UCLA Primary Care | 2019 (Cycle 29) | $932,434 |
| University of California, Los Angeles | Tobacco-Use Prevention and Cessation | |
| Characterization of innate immunity in pollution-induced exacerbation in Chronic Obstructive Pulmonary Disease (COPD) | 2019 (Cycle 29) | $933,635 |
| University of California, San Francisco | Pulmonary Disease | |
| Cancer prevention through low cost remediation of arsenic in drinking water | 2019 (Cycle 29) | $914,614 |
| University of California, Berkeley | Environmental Exposure/Toxicology | |
| E-Cigarette Aerosol Characterization Using Holography and Machine Learning | 2019 (Cycle 29) | $936,669 |
| University of California, Los Angeles | Environmental Exposure/Toxicology | |
| Evaluating Highly Selective Nicotinic Receptor Agonists and Antagonists | 2019 (Cycle 29) | $1,227,300 |
| California Institute of Technology | Neuroscience of Nicotine Addiction and Treatment | |
| Development of allosteric inhibitors against a molecular target (IKK) induced by cytokines and cigarette smoke | 2019 (Cycle 29) | $921,703 |
| University of California, San Diego | Cancer | |
2019 (Cycle 28)
| Genetic relationship between impulsivity and nicotine abuse | 2019 (Cycle 28) | $935,550 |
| University of California, San Diego | Neuroscience of Nicotine Addiction and Treatment | |
| Tobacco and Cannabis Intervention for Young Black MSM | 2019 (Cycle 28) | $1,106,197 |
| California State University, Long Beach Foundation | Tobacco-Use Prevention and Cessation | |
| Lung cancer cell response to Cdk4/6 inhibition | 2019 (Cycle 28) | $1,047,491 |
| University of California, Santa Cruz | Cancer | |
| Economic Impact of Proposition 56 on Low-Income Californians | 2019 (Cycle 28) | $917,959 |
| University of California, San Francisco | State and Local Tobacco Control Policy Research | |
| Exposure to Marijuana Smoking: the Effect of Proximity | 2019 (Cycle 28) | $1,137,361 |
| Stanford University | Environmental Exposure/Toxicology | |
| Stemness suppressors to combat aggressive breast cancers | 2019 (Cycle 28) | $933,655 |
| University of California, San Diego | Cancer | |
| E-Cigs Excite the Human Splenocardiac Axis: Role of Nicotine | 2019 (Cycle 28) | $935,983 |
| University of California, Los Angeles | Cardiovascular and Cerebrovascular Disease | |
| Systemic aging and salivary stem cells | 2019 (Cycle 28) | $934,778 |
| University of California, San Francisco | Oral Disease and Dental Health | |
| Role of DNA damage in Pulmonary Artery Hypertension | 2019 (Cycle 28) | $936,679 |
| University of California, San Francisco | Pulmonary Disease | |
| Health behaviors of 18-39 yo survivors of childhood cancers | 2019 (Cycle 28) | $670,328 |
| University of Southern California | Tobacco-Use Prevention and Cessation | |
| Measuring Environmental Tobacco and Cannabis | 2019 (Cycle 28) | $907,034 |
| University of California, San Francisco | Environmental Exposure/Toxicology | |
| Proximity to cannabis retailers & adolescent use | 2019 (Cycle 28) | $1,237,497 |
| University of Southern California | Tobacco-Use Prevention and Cessation | |
| Smoking Cessation in California Medicaid Programs | 2019 (Cycle 28) | $587,017 |
| University of California, San Diego | State and Local Tobacco Control Policy Research | |
| Genotoxic effects of alternative tobacco products & alcohol | 2019 (Cycle 28) | $1,297,500 |
| Beckman Research Institute of the City of Hope | Environmental Exposure/Toxicology | |
| Are smokers switching to vaping at lower risk for cancer? | 2019 (Cycle 28) | $1,229,278 |
| University of Southern California | Environmental Exposure/Toxicology | |
| MRI-Derived Risk Maps to Predict Prostate Cancer Progression | 2019 (Cycle 28) | $615,860 |
| University of California, San Francisco | Cancer | |
| The role of PKDs in atherosclerosis & coronary heart disease | 2019 (Cycle 28) | $933,858 |
| University of California, San Diego | Cardiovascular and Cerebrovascular Disease | |
| The effect of tobacco on oral mucosal renewal & regeneration | 2019 (Cycle 28) | $934,501 |
| University of California, San Francisco | Oral Disease and Dental Health | |
| Neuroinflammation and Smoking Cessation Treatment Response | 2019 (Cycle 28) | $1,066,612 |
| Veterans Medical Research Foundation | Neuroscience of Nicotine Addiction and Treatment | |
| Cannabis and Tobacco Co-Use and the Developing Brain | 2019 (Cycle 28) | $928,325 |
| University of California, San Diego | Neuroscience of Nicotine Addiction and Treatment | |
| Implementation Research to Cut Colorectal Cancer Disparities | 2019 (Cycle 28) | $910,175 |
| University of California, Los Angeles | Tobacco-Use Prevention and Cessation | |
| Obsessive-Compulsive Symptoms and Tobacco Dependence | 2019 (Cycle 28) | $1,235,906 |
| University of Southern California | Tobacco-Use Prevention and Cessation | |
| Tobacco Policies and Disparities: California vs. the US | 2019 (Cycle 28) | $933,303 |
| University of California, San Diego | State and Local Tobacco Control Policy Research | |
| Therapeutic targeting to inhibit lung fibrosis progression | 2019 (Cycle 28) | $925,286 |
| University of California, Davis | Pulmonary Disease | |
| GLP-1 Hormone in Severe Asthma | 2019 (Cycle 28) | $937,500 |
| University of California, Davis | Pulmonary Disease | |
| Tobacco regulation of amyloidogenic diseases | 2019 (Cycle 28) | $1,098,139 |
| Stanford University | Cardiovascular and Cerebrovascular Disease | |
| Molecular Pathogenesis & Therapy for Critical Limb Ischemia | 2019 (Cycle 28) | $935,403 |
| University of California, San Francisco | Cardiovascular and Cerebrovascular Disease | |
| Effects of Cigarette Smoking & Vaping on Heart Attack | 2019 (Cycle 28) | $1,066,980 |
| Huntington Medical Research Institute | Cardiovascular and Cerebrovascular Disease | |
| Smoking reinstatement in major depressive disorder | 2019 (Cycle 28) | $1,255,153 |
| University of Southern California | Tobacco-Use Prevention and Cessation | |
2018 (Cycle 27)
| Tobacco Smoke Exposure and Atrial Fibrillation | 2018 (Cycle 27) | $903,503 |
| University of California, San Francisco | Cardiovascular and Cerebrovascular Disease | |
| Improving diagnostic and therapeutic imaging tools for COPD | 2018 (Cycle 27) | $919,571 |
| University of California, Los Angeles | Pulmonary Disease | |
| SRF Phosphorylation and the Progression to Heart Failure | 2018 (Cycle 27) | $1,209,921 |
| Stanford University | Cardiovascular Disease | |
| Role of a Critical Cell Surface Molecule in Tobacco-induced Lung Immune Cell Trafficking | 2018 (Cycle 27) | $1,002,925 |
| Palo Alto Veterans Institute For Research | Pulmonary Disease | |
| Tobacco Exposure and Asthma Disparity in Minority Children | 2018 (Cycle 27) | $935,584 |
| University of California, San Francisco | Pulmonary Disease | |
| DEVELOPMENTAL NICOTINE EXPOSURE: NEUROTRANSMITTER PLASTICITY | 2018 (Cycle 27) | $926,775 |
| University of California, San Diego | Neuroscience of Nicotine Addiction and Treatment | |
| Toxicants and Cardiovascular Effects: Cannabis vs Tobacco | 2018 (Cycle 27) | $929,782 |
| University of California, San Francisco | Environmental Exposure/Toxicology | |
| Marijuana Dispensaries and Adolescents' Use of Marijuana and Tobacco | 2018 (Cycle 27) | $895,649 |
| University of California, San Diego | Tobacco-Use Prevention and Cessation | |
| Natural Products for the Treatment of Never Smoker Lung Cancer | 2018 (Cycle 27) | $935,133 |
| University of California, Santa Cruz | Environmental Exposure/Toxicology | |
| Pulmonary Innate Lymphoid Cells and airway inflammation in COPD | 2018 (Cycle 27) | $937,500 |
| University of California, Davis | Pulmonary Disease | |
| Parkin-mediated mitochondrial quality control and cardiovascular disease | 2018 (Cycle 27) | $937,500 |
| University of California, San Diego | Cardiovascular and Cerebrovascular Disease | |
| Evaluation of the Tobacco Prevention Toolkit | 2018 (Cycle 27) | $1,175,996 |
| Stanford University | Tobacco-Use Prevention and Cessation | |
| Immune reactivity across the spectrum of disease in lung adenocarcinoma | 2018 (Cycle 27) | $937,158 |
| University of California, Los Angeles | Environmental Exposure/Toxicology | |
| Redefining KRAS dependency as a stress-inducible state | 2018 (Cycle 27) | $935,535 |
| University of California, San Diego | Environmental Exposure/Toxicology | |
| Exposure to Tobacco, E-Cigarette, and Marijuana in Mutlin-Unit Housing | 2018 (Cycle 27) | $1,095,903 |
| San Diego State University Research Foundation | Environmental Exposure/Toxicology | |
| Tobacco smoking and inborn genetics: effects on leukemogenesis | 2018 (Cycle 27) | $1,215,889 |
| University of Southern California | Cancer | |
| E-cigarette vaping, chemical composition and lung toxicity | 2018 (Cycle 27) | $910,493 |
| University of California, Davis | Environmental Exposure/Toxicology | |
| Human iPSCs for Elucidating Cardiovascular Risks of E-Cigarettes | 2018 (Cycle 27) | $1,197,500 |
| Stanford University | Cardiovascular and Cerebrovascular Disease | |
| Smoking in California drug treatment: A policy intervention | 2018 (Cycle 27) | $931,110 |
| University of California, San Francisco | State and Local Tobacco Control Policy Research | |
| Vaping Nicotine and Cannabis in Adolescence and Early Adulthood | 2018 (Cycle 27) | $1,230,250 |
| University of Southern California | Tobacco-Use Prevention and Cessation | |
| Effects of nicotine e-cigarette self-administration on addiction | 2018 (Cycle 27) | $459,503 |
| Scripps Research Institute | Neuroscience of Nicotine Addiction and Treatment | |
| S-Nitrosylation of DNMTs in epigenetic regulation of tumors | 2018 (Cycle 27) | $1,448,303 |
| Scripps Research Institute | Cancer | |
| Impact of new policies on young adult tobacco and marijuana | 2018 (Cycle 27) | $908,748 |
| University of California, San Francisco | State and Local Tobacco Control Policy Research | |
2017 (Cycle 26)
| Readiness for and obstacles to California's tobacco endgame | 2017 (Cycle 26) | $375,526 |
| University of California, San Francisco | State and Local Tobacco Control Policy Research | |
| Southern California Vape Shop Reactions to New Policies | 2017 (Cycle 26) | $495,000 |
| University of Southern California | State and Local Tobacco Control Policy Research | |
| Impacts of Electronic Cigarette Emissions on Indoor Air Quality | 2017 (Cycle 26) | $373,096 |
| University of California, Los Angeles | Environmental Exposure/Toxicology | |
| Improved identification of subjects genetically at risk for lung cancer | 2017 (Cycle 26) | $495,000 |
| University of Southern California | Early Diagnosis of Tobacco-Related Cancer | |
| Put It Out Project for Sexual and Gender Minority Smokers | 2017 (Cycle 26) | $386,973 |
| University of California, San Francisco | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| Double-strand Break by THS: Implications for Tobacco Cancer | 2017 (Cycle 26) | $581,626 |
| Lawrence Berkeley National Laboratory | Environmental Exposure/Toxicology | |
| Prenatal tobacco smoke exposure and somatic alterations in childhood ALL | 2017 (Cycle 26) | $166,601 |
| University of California, San Francisco | Environmental Exposure/Toxicology | |
| The Economic Impact of the California Tobacco 21 Law | 2017 (Cycle 26) | $374,819 |
| University of California, San Francisco | State and Local Tobacco Control Policy Research | |
| Project Towards No Nicotine: Afterschool Tobacco Use Prevention Program | 2017 (Cycle 26) | $397,095 |
| University of California, Los Angeles | Tobacco-Use Prevention and Cessation | |
| Lung Cancer Screening: A Multilevel Intervention | 2017 (Cycle 26) | $374,770 |
| University of California, San Francisco | Early Diagnosis of Tobacco-Related Cancer | |
| An IFN-gamma/mast cell axis in THS-exacerbated allergic airway inflammation | 2017 (Cycle 26) | $478,312 |
| Stanford University | Environmental Exposure/Toxicology | |
| Triangulum (Tobacco, E-Cigarettes, Marijuana) SHS exposure in Low SES MUH | 2017 (Cycle 26) | $495,000 |
| University of Southern California | State and Local Tobacco Control Policy Research | |
| Tobacco and Marijuana Co-Use Among Emerging Adults in California | 2017 (Cycle 26) | $466,934 |
| RAND Corporation | Tobacco-Related Health Disparities | |
| Investigating the carcinogenic potential of e-cig in humans | 2017 (Cycle 26) | $474,971 |
| University of Southern California | Early Diagnosis of Tobacco-Related Cancer | |
| Did CTCP impact on youth affect lifetime cigarettes smoked? | 2017 (Cycle 26) | $186,238 |
| University of California, San Diego | State and Local Tobacco Control Policy Research | |
| Prenatal tobacco smoke exposure and somatic alterations in childhood ALL | 2017 (Cycle 26) | $207,122 |
| University of Southern California | Environmental Exposure/Toxicology | |
| The impact of price on the demand for electronic cigarettes | 2017 (Cycle 26) | $374,677 |
| University of California, San Francisco | State and Local Tobacco Control Policy Research | |
| SGLT2 in early diagnosis and treatment of lung cancer | 2017 (Cycle 26) | $414,716 |
| University of California, Los Angeles | Early Diagnosis of Tobacco-Related Cancer | |
| Effects of California's 2016 tobacco policies on initiation, use, & quitting | 2017 (Cycle 26) | $374,400 |
| University of California, San Francisco | State and Local Tobacco Control Policy Research | |
| Barriers and Supports for Smoking Cessation: Latinos in Addiction Treatment | 2017 (Cycle 26) | $498,793 |
| HBSA, Inc. | Tobacco-Related Health Disparities | |
| Computer Vision for Detection of Tobacco Related Diseases on | 2017 (Cycle 26) | $365,413 |
| University of California, Los Angeles | Early Diagnosis/Pathogenesis | |
| Longitudinal Effects of Nicotine on the Developing Adolescent Brain | 2017 (Cycle 26) | $65,130 |
| University of California, Los Angeles | Neuroscience of Nicotine Addiction and Treatment | |
| Role of a6* nAChR-mediated signaling in nicotine withdrawal | 2017 (Cycle 26) | $579,971 |
| SRI International | Neuroscience of Nicotine Addiction and Treatment | |
| Nicotine metabolism and predicting lung cancer risk in African Americans | 2017 (Cycle 26) | $496,005 |
| University of Southern California | Early Diagnosis of Tobacco-Related Cancer | |
| Is Electronic Cigarette Aerosol Residue Hazardous? | 2017 (Cycle 26) | $385,491 |
| University of California, Riverside | Environmental Exposure/Toxicology | |
2016 (Cycle 25)
| Measuring combined tobacco, e-cigarette, and marijuana use | 2016 (Cycle 25) | $374,448 |
| University of California, San Francisco | Tobacco-Related Health Disparities | |
| Cardiovascular Toxicity of E-Cigarettes: Role of Nicotine | 2016 (Cycle 25) | $391,200 |
| University of California, Los Angeles | Cardiovascular Disease | |
| Tobacco/marijuana smoke: from lab to public health policy | 2016 (Cycle 25) | $373,988 |
| University of California, San Francisco | Environmental Exposure/Toxicology | |
| Effect of voltage on electronic cigarette aerosol deposition | 2016 (Cycle 25) | $372,621 |
| University of California, San Francisco | Environmental Exposure/Toxicology | |
| Toward Equity in Smokefree Worksite Policies, SHS Exposure & Retail Density | 2016 (Cycle 25) | $388,371 |
| Stanford University | State and Local Tobacco Control Policy Research | |
| Youth Activity Spaces and Exposure to Tobacco Outlets | 2016 (Cycle 25) | $457,273 |
| HBSA, Inc. | State and Local Tobacco Control Policy Research | |
| Do Assurances of Voluntary Compliance Reduce Youth Access and Marketing? | 2016 (Cycle 25) | $461,386 |
| Stanford University | State and Local Tobacco Control Policy Research | |
| EX-Teen American Indian Tobacco Use Cessation Program | 2016 (Cycle 25) | $495,000 |
| University of Southern California | Tobacco-Use Prevention and Cessation | |